Business Description
Arrowhead Pharmaceuticals is a US-based drug development company focused on creating treatments for serious and hard-to-treat diseases. The company uses RNA interference technology to develop a broad range of experimental therapies targeting conditions related to the liver, heart, kidneys, and other areas, with several candidates already in advanced clinical trials. Arrowhead works alongside major pharmaceutical partners including GSK, Takeda, Amgen, and Sarepta Therapeutics. Founded in 2003 and based in Pasadena, California, the company continues to grow its pipeline of next-generation medicines.
